Skip to main content
Smart Investors Daily
FI

NYSE · FIGS

FIGS, Inc.

Consumer Cyclical · Apparel - Manufacturers

$20.82

Up+$1.19 (+5.72%)

Updated Nov 4, 2026, 7:03 PM

SID Score

5.3/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.91B
P/E ratio
108.49
Dividend yield
0.00%
52-week range
$9.17 – $22.46
Volume
8.22M
Avg. volume
2.3M

Price performance · FIGS

FIGS price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 3, 2026

FIGS closed at $20.82 after 21 trading sessions, up 47.66% for the selected period.

Last close
$20.82
Period change
+47.66%
Period low
$14.06
Period high
$21.56
Daily close
View OHLC price history
FIGS OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 3, 2026$21.29$21.62$20.64$20.828.22M
Nov 2, 2026$21.74$22.4576$21.27$21.293.58M
Oct 30, 2026$21.44$21.70$20.77$21.312.74M
Oct 29, 2026$21.00$22.305$21.00$21.564.78M
Oct 28, 2026$20.01$20.785$20.01$20.663.22M
Oct 27, 2026$20.64$20.88$19.88$20.482.75M
Oct 26, 2026$20.23$20.865$20.20$20.832.17M
Oct 23, 2026$20.23$20.7251$20.09$20.202.85M
Oct 22, 2026$20.20$20.86$20.025$20.462.58M
Oct 21, 2026$19.90$20.4577$19.60$19.983.95M
Oct 20, 2026$19.575$20.21$19.49$19.863.32M
Oct 19, 2026$19.16$19.57$18.9311$19.453.39M
Oct 16, 2026$19.88$20.31$18.66$19.125.29M
Oct 15, 2026$18.495$19.71$18.32$19.544.41M
Oct 14, 2026$17.89$18.73$17.46$18.635.77M
Oct 13, 2026$17.80$19.18$17.58$18.006.72M
Oct 12, 2026$15.89$17.979$15.865$17.7411.31M
Oct 9, 2026$14.99$15.8881$14.92$15.783.76M
Oct 8, 2026$14.16$15.04$13.979$14.985.97M
Oct 7, 2026$14.05$14.66$13.94$14.067.25M
Oct 6, 2026$13.77$14.435$13.655$14.103.96M

Latest FIGS news

The latest Smart Investors Daily articles mentioning FIGS.

FIGS research

Overview

Company profile and research snapshot.

Company profile

FIGS Inc is a healthcare apparel company. The Company designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear and other apparel. The Company generates maximum revenue from United States. Sales are generated through the Company's digital platforms.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$15.00
Implied upside
—
Analysts
—
FIGS recent ratings
DateFirmRatingTarget
Nov 3, 2026BarclaysOverweight—
Oct 30, 2026BTIGBuy—
Oct 29, 2026OppenheimerOutperform—
Aug 7, 2026Telsey Advisory GroupMarket Perform—
Aug 7, 2026KeybancOverweight—
Open full forecast

News briefing

Generated Nov 4, 2026, 3:25 PM

Why Is FIGS Up 6.58% Today?

FIGS, Inc. gained $1.37 per share (6.58%) today, driven by positive portfolio positioning news from the Baron Focused Growth Fund's Q3 2026 report. The healthcare apparel company appears to have caught the attention of prominent institutional investors, suggesting renewed confidence in its growth trajectory and market positioning.

    Bottom line: FIGS' 6.58% gain reflects institutional validation through Baron Fund inclusion, suggesting renewed confidence in the healthcare apparel company's growth story. While today's movement is positive, investors should monitor whether this represents sustained fundamental improvement or temporary momentum, and watch for upcoming earnings reports to confirm operational progress.

    Yahoo · Oct 30, 2026

    Analyst Upgrade Could Be A Game Changer For FIGS Stock (FIGS)

    FIGS is preparing to report third quarter 2026 results, with Wall Street expecting higher earnings supported by stronger revenue from its healthcare apparel and lifestyle offering. Analysts are watching how FIGS converts healthcare professionals' recurring uniform budgets into direct to consumer sales while managing freight and tariff costs that affect margins. This article will examine how these earnings expectations and operational factors may influence the investment narrative ahead of...

    AI research layers

    Interpretive context generated from the platform’s current data sources.

    No results

    AI research layers have not been published yet.